[1] |
Dai Leheng, Hu Wen, Zhang Kunjie, Kang Xiaojing.
Protective effects of isorhamnetin against H2O2-induced mitochondrial structural and functional damage in HaCaT cells
[J]. Chinese Journal of Dermatology, 2023, 56(9): 857-861.
|
[2] |
Liu Yuanxiang, Liang Yuan, Zhao Xinrong, Sun Yujuan, Ma Lin, Xu Zigang.
Janus kinase inhibitors for the treatment of five children with severe alopecia areata
[J]. Chinese Journal of Dermatology, 2023, 56(9): 849-852.
|
[3] |
Liu Xiaoyang, Zhao Yan, Cai Lin, Zhang Jianzhong.
Atopic dermatitis-like lesions appearing after interleukin-17 antagonist therapy in 4 cases of psoriasis: case analysis and literature review
[J]. Chinese Journal of Dermatology, 2023, 56(9): 845-848.
|
[4] |
Fu Dandan, Li Jialin, Fu Xiuyu, Zhang Xinyu, Hu Hua, Song Xiangfeng, Tian Zhongwei.
S100A10 protein expression in psoriatic lesions and its effect on psoriasis-like skin inflammation in mouse models
[J]. Chinese Journal of Dermatology, 2023, 56(9): 839-844.
|
[5] |
Wang Junxia, Guo Weinan, Chen Hui, Hao Junfeng, Li Bing, Wei Jingyi, Zhao Tao.
Efficacy of autologous fat grafting in the treatment of 40 cases of stable linear scleroderma: a retrospective analysis
[J]. Chinese Journal of Dermatology, 2023, 56(8): 762-765.
|
[6] |
Jiang Xiaoyan, Gao Min, Zhang Xiaoyan, Liu Ningyuan.
Interleukin-17 and interleukin-23 inhibitors in the treatment of pustular psoriasis
[J]. Chinese Journal of Dermatology, 2023, 56(7): 689-692.
|
[7] |
Yang Nali, Xu Qiuyang, Wu Hanwen, Ye Yahui, Zhu Jiling, Liu Jingjing, Li Zhiming.
Efficacy and safety of omalizumab in the treatment of chronic urticaria: a retrospective analysis
[J]. Chinese Journal of Dermatology, 2023, 56(6): 518-524.
|
[8] |
Su Chang, Sui Xiuli, Liu Ruiling, Cao Yiqun, Jiang Hong, Yan Cairong, Wang Huiping, Qi Yuqing.
Omalizumab for the treatment of 74 patients with chronic spontaneous urticaria accompanied by other allergic diseases: a clinical analysis
[J]. Chinese Journal of Dermatology, 2023, 56(6): 512-517.
|
[9] |
Wang Xin, Liu Lijuan, Li Linfeng.
Clinical features of chronic spontaneous urticaria in China: results from a hospital-based multicenter epidemiological survey
[J]. Chinese Journal of Dermatology, 2023, 56(6): 525-530.
|
[10] |
Li Liqiao, Peng Cong, Chen Xiang, Li Jie.
Efficacy of omalizumab in the treatment of chronic urticaria patients with poor response to antihistamines: a single-center retrospective study
[J]. Chinese Journal of Dermatology, 2023, 56(6): 504-511.
|
[11] |
Jia Weixue, Li Chengrang.
Comparison of Chinese and international guidelines and consensus for the diagnosis and treatment of vitiligo
[J]. Chinese Journal of Dermatology, 2023, 56(5): 471-475.
|
[12] |
Chen Yi, Song Xiuzu.
Role of transient receptor potential channels in melanocytes and their related diseases
[J]. Chinese Journal of Dermatology, 2023, 56(4): 376-379.
|
[13] |
Guo Weinan, Wang Junxia, Chen Hui, Hao Junfeng, Li Bing, Wei Jingyi, Zhao Tao.
Clinical efficacy of autologous adipose-derived stem cell gel grafting in the treatment of depressed acne scars
[J]. Chinese Journal of Dermatology, 2023, 0(3): 20210867-e20210867.
|
[14] |
Zhou Jian, Yu Chen, Wang Gang.
Clinical efficacy and safety of secukinumab in the treatment of 13 cases of refractory localized pustular psoriasis
[J]. Chinese Journal of Dermatology, 2023, 56(3): 247-251.
|
[15] |
Hu Kun, Yang Jing, Wang Qiaolin, Chen Junchen, Zhang Mi, Zhu Wu, Zhang Bin, Dou Guanshen, Wendong Chen, Kuang Yehong.
Real-world short-term treatment effects of Ixekizumab in Chinese patients with psoriasis: a single-center retrospective study
[J]. Chinese Journal of Dermatology, 2023, 56(3): 210-215.
|